ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2015

Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response.

Marco Pizzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.